2026 NPPES data Sleep Medicine (Family Medicine) Physician NPI 1427163955 MD
Verify on CMS →

MICHAEL CASAGRANDE, MD

Sleep Medicine (Family Medicine) Physician in TOMBALL, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
6K
Medicare Part D claims · 684 beneficiaries · Sleep Medicine (Family Medicine) Physician avg: 2K
Generic prescribing
78%
generic claims · 22% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
70.1182/100
▼ 13 pts below national avg 83.1 · [object Object]
Industry payments
$2.7K
114 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MICHAEL CASAGRANDE, MD reported a CMS MIPS final score of 70.1182/100 — below the 83.1 national average — and filed 6,467 Medicare Part D claims in 2023.

70.1182/100
MIPS score · -13 vs avg
6K
Part D claims, 2023
78%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MICHAEL CASAGRANDE, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

70 8th percentile higher than 8% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MICHAEL CASAGRANDE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MICHAEL CASAGRANDE, MD?

Below national average

NPI registry status

Active

Issued 08/21/2006

NPI 1427163955

Primary specialty

Sleep Medicine (Family Medicine) Physician

Rare

190 US NPIs in this specialty

Medicare Part D claims

6,467 329% vs specialty avg

2023 prescription claims

Specialty avg: 1,506

MIPS final score

70.1182/100 12.981799999999993% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Texas

How Sleep Medicine (Family Medicine) Physician compares to other specialties among Texas providers

Texas providers

Sleep Medicine (Family Medicine) Physician share within Texas

1. Sleep Medicine (Family Medicine) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Sleep Medicine (Family Medicine) Physician share within Texas

Medicare quality performance — MIPS

MICHAEL CASAGRANDE, MD's 2023 MIPS final score plotted against the Sleep Medicine (Family Medicine) Physician national average

Below national average
MIPS Final Score
70.1182/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Sleep Medicine (Family Medicine) Physician) — 70.1182/100 vs national avg 83.1

0%100%National avg83%70.1%
MIPS final score (Sleep Medicine (Family Medicine) Physician) — 70.1182/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHAEL CASAGRANDE, MD appears in the CMS NPPES registry as a Sleep Medicine (Family Medicine) Physician provider holding MD credentials at 13628 MICHEL RD, TOMBALL, TX, 77375, with a listed phone of (281) 357-1934. NPI 1427163955 was issued on 08/21/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CASAGRANDE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 6,467 prescription claims written by this provider, covering 684 Medicare beneficiaries and totaling roughly $1.3 million in drug spend, split 22% brand-name and 78% generic by claim count, with an opioid prescribing rate of 1.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 70.1182/100 for the 2023 performance year (Quality 83.6439, Cost 22.202), compared with the national average of 83.1.

Sleep Medicine (Family Medicine) Physician is a narrow specialty nationwide, with 190 enrolled providers across 45 states and an average of 1,506 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

13628 MICHEL RD
TOMBALL, TX 77375

Provider Details

NPI 1427163955
Specialty Sleep Medicine (Family Medicine) Physician
Credentials MD
Gender Male
NPI Issued 08/21/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

70.1182
Final Score
Avg: 83.1
83.6439
Quality
22.202
Cost

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MICHAEL CASAGRANDE, MD. Source: openpaymentsdata.cms.gov.

Total received

$2.7K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to MICHAEL CASAGRANDE, MD. To verify MICHAEL CASAGRANDE, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MICHAEL CASAGRANDE, MD — brand share 22.0%
Specialty average (est.)

22% brand-name claims vs 78% generic, on 6,467 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

6,467
Total Claims
$1.3M
Total Drug Cost
684
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
12,999
Total Day Supply
376,028
Brand vs Generic
22% brand / 78% generic
Brand Drug Cost
$1.2M
Generic Drug Cost
$121K
Opioid Claims
91 (1.4% rate)
Antibiotic Claims
149

Patient Demographics

Average Patient Age
75.1 years
Avg HCC Risk Score
1.34
Gender Split
52% female / 48% male
Age Distribution
<65: 22, 65-74: 314, 75-84: 277, 85+: 71

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MICHAEL CASAGRANDE, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
366
Atorvastatin Calcium
197
Lisinopril
189
Metformin Hcl
182
Farxiga
Dapagliflozin Propanediol
175
Rosuvastatin Calcium
154
Pantoprazole Sodium
151
Metoprolol Succinate
144
Jardiance
Empagliflozin
133
Furosemide
132

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Sleep Medicine (Family Medicine) Physician Overview

How MICHAEL CASAGRANDE, MD fits within the Sleep Medicine (Family Medicine) Physician landscape nationally.

190
Sleep Medicine (Family Medicine) Physician Providers in US
45
States with Sleep Medicine (Family Medicine) Physician
1,506
Avg Claims per Provider

MICHAEL CASAGRANDE, MD's 6,467 claims are above the specialty average of 1,506.

Nearby Sleep Medicine (Family Medicine) Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as CASAGRANDE.

Compare Sleep Medicine (Family Medicine) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHAEL CASAGRANDE, MD's specialty?
MICHAEL CASAGRANDE, MD specializes in Sleep Medicine (Family Medicine) Physician and practices in TOMBALL, Texas. Credentials: MD.
How much does MICHAEL CASAGRANDE, MD prescribe under Medicare Part D?
In 2023, MICHAEL CASAGRANDE, MD wrote 6,467 Medicare Part D claims totaling $1.3M in drug costs for 684 beneficiaries.
What is MICHAEL CASAGRANDE, MD's Medicare quality score?
MICHAEL CASAGRANDE, MD has a CMS MIPS Final Score of 70.1182/100 (Quality: 83.6439, Cost: 22.202). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MICHAEL CASAGRANDE, MD located?
MICHAEL CASAGRANDE, MD is located at 13628 MICHEL RD, TOMBALL, TX, 77375. Phone: (281) 357-1934.
What is MICHAEL CASAGRANDE, MD's NPI number?
MICHAEL CASAGRANDE, MD's National Provider Identifier (NPI) is 1427163955, issued on 08/21/2006.
Does MICHAEL CASAGRANDE, MD prescribe more brand-name or generic drugs?
MICHAEL CASAGRANDE, MD's prescribing is 22% brand-name and 78% generic drugs by claim count, with $1.2M in brand drug costs.
Does MICHAEL CASAGRANDE, MD prescribe opioids?
Yes, MICHAEL CASAGRANDE, MD had 91 opioid claims in 2023 with an opioid prescribing rate of 1.4%.
How many Sleep Medicine (Family Medicine) Physician providers are there in the US?
There are 190 Sleep Medicine (Family Medicine) Physician providers across 45 states in the US. The average Sleep Medicine (Family Medicine) Physician provider writes 1,506 Medicare Part D claims per year.
What drugs does MICHAEL CASAGRANDE, MD prescribe most often?
Based on 2023 Medicare Part D data, MICHAEL CASAGRANDE, MD's most frequently prescribed drugs include Levothyroxine Sodium, Atorvastatin Calcium, Lisinopril. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHAEL CASAGRANDE, MD accept Medicare?
MICHAEL CASAGRANDE, MD appears in CMS Medicare data with 6,467 Part D claims and 684 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHAEL CASAGRANDE, MD's credentials?
MICHAEL CASAGRANDE, MD's NPI is 1427163955 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology